BK Clinical Trials Consulting Holding ApS — Credit Rating and Financial Key Figures

BK Clinical Trials Consulting Holding ApS (CVR number: 37087858) is a company from RUDERSDAL. The company recorded a gross profit of -6.1 kDKK in 2023. The operating profit was -6.1 kDKK, while net earnings were -6.4 kDKK. The profitability of the company measured by Return on Assets (ROA) was -16.4 %, which can be considered poor and Return on Equity (ROE) was -30.2 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 48.8 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. BK Clinical Trials Consulting Holding ApS's liquidity measured by quick ratio was 2 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.